Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.

ABSTRACT: An amendment to this paper has been published and can be accessed via a link at the top of the paper.

SUBMITTER: Ribi K 

PROVIDER: S-EPMC7109133 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature